$ABCL stock is up 11% today. Here's what we see in our data. - Nasdaq
1 weeks ago • Google News
Abcellera Biologics Inc (ABCL)
US$ 2.421.26%
Price Chart
Key Statistics
Market Cap
$ 931.27M
P/E Ratio
0.00
Revenue (TTM)
$ 23.11M
Volume
2.97M
52W High
$ 3.68
52W Low
$ 1.89
Dividend Yield
0.00%
Beta
0.36
Technicals
50-Day MA
2.3474
200-Day MA
2.6645
52 Week High
3.68
52 Week Low
1.8906
About ABCL
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
Employees
596
Headquarters
Vancouver, BC
CEO
Dr. Carl L.G. Hansen Ph.D.
Latest News
ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why - MSN
6 days ago • Google News
AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential - Yahoo Finance
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg